This brand name is authorized in Austria, Australia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Israel, Japan, Lithuania, Mexico, Nigeria, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa
The drug MINIRIN contains one active pharmaceutical ingredient (API):
1
Desmopressin
UNII XB13HYU18U - DESMOPRESSIN ACETATE
|
Desmopressin is a structural analogue of vasopressin in which the antidiuretic activity has been enhanced by the order of 10, while the vasopressor effect has been reduced by the order of 1500. The clinical advantage of this highly changed ratio of antidiuretic to vasopressor effect is that clinically active antidiuretic doses are far below the threshold for a vasopressor effect. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
H01BA02 | Desmopressin | H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BA Vasopressin and analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2129C, 8662X, 8663Y, 8711L, 8712M, 8975J, 9398P |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 1973-MEE-0416, 29114-12-09 |
Country: EE | Ravimiamet | Identifier(s): 1026492, 1064348, 1064360, 1064382, 1225550, 1225561, 1225572, 1225583, 1225594, 1225606, 1225617, 1225628, 1225639 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 022235, 022246, 022255, 022266, 022279, 022288, 022310, 022323, 456491 |
Country: FR | Base de données publique des médicaments | Identifier(s): 62263894, 62822682, 64479727, 66842127, 67275313, 67576220, 69584479 |
Country: HK | Department of Health Drug Office | Identifier(s): 30497, 30498, 32872, 37370, 37371, 54452, 54453, 66247 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-052219211, HR-H-584681917, HR-H-794064519 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4410, 4411, 6063, 6064 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2419001F1023, 2419001F2020, 2419001F3026, 2419001F4022, 2419001F5029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1001285, 1001286, 1001287, 1005614, 1005616, 1022380, 1022383, 1022385, 1022386 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 021M2009, 197M97, 520M96 |
Country: NG | Registered Drug Product Database | Identifier(s): B4-9870, B4-9871 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 12291, 12292, 12293, 2110, 2112, 2113 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100081060, 100081076, 100096014, 100096936, 100179390, 100179438, 100179450 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W53989001, W53991001, W53991002, W53992001, W53992002, W53994001, W53994002 |
Country: SG | Health Sciences Authority | Identifier(s): 03760P, 03761P, 04482P, 11615P, 11656P, 14260P, 14261P, 15615P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 2593021, 2593022, 2593023, 2593024, 5523011, 5523012, 5523013, 5523051 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8697621010314, 8697621010321, 8697621010420, 8697621050211, 8697621050228, 8697621050235, 8697621050242, 8697621050372, 8697621050389, 8697621050457, 8697621050501, 8697621050518, 8697621540330, 8697621750357 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 42/18.2/0345, 42/18.2/0346, 42/18.2/0347 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.